Healthcare practitioners

Make this educational program available to all healthcare practitioners involved in the patient s care,... 

The astute individual healthcare practitioner is the critical link in the postmarketing surveillance of medical products. One reporter can indeed make a difference in a newly approved drug s postmarketing phase. Only through the diligence of individual practitioners, such as pharmacists, can FDA hope to monitor the adverse events associated with newly marketed products and determine their safety for patient use. 

CRBPC s Rx D Code of Marketing Practice provides that member companies must not distribute service-oriented items or conduct "special promotions", which cannot be justified if subjected to scrutiny by members of the health professions and the public (CRBPC 2005). Acceptable service-oriented items are defined as items the primary goal of which is to enhance the healthcare practitioner s/patient s understanding of a condition or its treatment. When member companies provide hospitality, they must ensure that all hospitality is conducted within the limits of acceptable public and professional scrutiny, keeping in mind the need for an ethical relationship in any social interaction between healthcare professionals and pharmaceutical companies (CRBPC 2005). During such interactions, companies may provide participants with refreshments/meals that are modest in content and cost. In all instances, the provision of refreshments/meals must be clearly incidental. No other form of hospitality or entertainment is to be provided. 

Providing scientific sophistication for healthcare practitioners yet easily understood by the interested layman, this book—... 

Young, L.R. Wurtzbacher, J.D. Blankenship, C.S. Adverse drug reactions a review for healthcare practitioners. Am. J. Managed Care 1997, 12, 1884-1906. 

The prevention of medication errors is the primary objective of the USP MER Program. It collects and analyzes potential and actual medication errors submitted by healthcare practitioners. The program affords healthcare professionals the opportunity to report medication errors and thereby to contribute to improving patient safety by sharing their experiences. 

Healthcare practitioner authorised to request or order medication... 

In addition to written requests by a variety of healthcare practitioners and other authorised individuals (see Section 5.2), some requests for the supply of medication do not have to be written down (i.e. via a written requisition). These are termed oral requisitions. 

Clinical Chemistry, Laboratory Medicine, and Evidence-Based Laboratory Medicine In this chapter, we review the new influences on clinical chemistry and laboratory medicine from the fields of cfinical epidemiology and evidence-based medicine (EBM). Cfinical epidemiologists have developed study designs to quantify the diagnostic accuracy of the tests developed in laboratory medicine, and study methods to evaluate the effect and value of laboratory testing in healthcare. Practitioners of EBM focus on use of the best available evidence from such well-designed studies in the care of individual patients. EBM rephrases problems in the clinical care of patients as structured clinical questions, looks for the available evidence, evaluates the quality of cfinical studies, evaluates the clinical implications of the results, and provides tools to help clinicians optimally use those results in the care of individual patients. 

To provide professional support for healthcare practitioners in preventing and handling medication errors. 

Safe Medication Management Fellowship that provides postgraduate training to healthcare practitioners in safe medication management. 

To maintain a national medication error reporting program to collect observations and experiences of healthcare practitioners and to analyze this information with a systems approach in order to draw valid... 

The Foundation held the Second National Congress on Pharmaceutical Care November 2001 in Barcelona. The main subject of this congress was communication with patients and with the other healthcare practitioners. The Foundation believes that communication skills are the main deficiencies of community pharmacists, and these are essential for pharmaceutical care implementation and practice. 

MedWatch. URL http //www.fda.gov/medwatch/index.html. The FDA s MedWatch Web site outlines procedures for voluntary reporting of serious adverse events or product problems by consumers and healthcare practitioners. It also includes... 

Parallel to many technological developments, the twentieth century saw an evolution of medical ethics and medical legislation that went way beyond the content of the Hippocratic Oath. The need for all these considerations was precisely because the Hippocratic Oath provided no guidance to twentieth and early twenty-first century issues, such as the patient s rights, the ethics of experimentation, team care, and a medical researcher s or healthcare practitioner s societal or legal responsibilities. 

Photosafety testing (testing for adverse effects of drug products in the presence of light) is recommended only when it is felt that the results of such testing would yield important safety information or would be informative for the consumer and healthcare practitioner. 

The possibility that biological weapons will be used against us is no longer unthinkable. Until recently, medical officers and other healthcare practitioners may have considered this topic more suitable for academic than practical pursuit. The fact is, however, that biological agents have been used as weapons since antiquity, and the threat that modern weapons will be used is real. In fact, Saddam Hussein s aggression in the Persian Gulf War may... 

Not for use in pregnancy except under the supervision of a qualified healthcare practitioner (Bensky et al. 2004 Chen and Chen 2004). 

A review of 69 published and unpublished case reports of black cohosh-associated hepatotoxicity indicated that there was an excluded, unlikely, unrelated, or unassess-able causality for black cohosh in 68 of 69 cases and "little, if any, supportive evidence for a significant hepatotoxic risk of black cohosh" (Teschke et al. 2009). Although one animal study on black cohosh rhizome has identified a biologically plausible mechanism of hepatotoxicity at high dose levels (Liide et al. 2007), no changes in liver enzyme levels have been observed in several human studies (Bai et al. 2007 Nasr and Nafeh 2009 Osmers et al. 2005 van Breemen et al. 2009). Healthcare practitioners and consumers should be aware of the possible association between products containing black cohosh and hepatotoxicity. 

---